Loic Vincent (Takeda)
Takeda goes all in with build-to-buy play, picking up Maverick and its clinic-ready T cell engagers for $525M
As soon as Takeda and Maverick tied the bow on a $125 million pact in 2017, a countdown was set off: The pharma giant …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
